. "Preclinical Changes in Immunoreactivity and Cellular Architecture during the Progressive Development of Intracranial Neoplasms and an Immunotherapeutic Schedule with a Novel Biological Response Modifier, the T11TS / S-". Asian Pacific Journal of Cancer Prevention, 3, 4, 2002, 325-337.